Q1 2019 Dynavax Technologies Corp Earnings Call Transcript
Good day, ladies and gentlemen and welcome to the Dynavax Technologies First Quarter 2019 Conference Call. As a reminder, this conference call is being recorded.
I would now like to introduce your host for today's conference, Miss Heather Rowe, Vice President of Investor Relations and Corporate Communications. You may begin.
Thank you, operator. Good afternoon. Welcome to the Dynavax First Quarter 2019 Financial Results and Corporate Update Conference Call. With me today are Eddie Gray, Chief Executive Officer; Michael Ostrach, Chief Financial Officer; Rob Janssen, Chief Medical Officer; and Ryan Spencer, Vice President of Corporate Strategy and Commercial Operations.
Before we begin, I advise you that we will be making forward-looking statements today, including statements regarding clinical and financial information, expectations regarding HEPLISAV-B, including the amount and timing of sales, revenue and profitability; rates of adoption and reorder
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |